These inhibitors can, respectively, inhibit the palmitoylation or polymerization process of STING, significantly alleviating the symptoms of inflammatory skin diseases such as psoriasis (Sun et al., 2024; Holm et al., 2012). Here, STING1 is linked to psoriasis.